Well, I'd love to tell you that the Paxil study in children that was carried out in Japan was deemed a failure. Truth is, I don't know and Glaxo, it appears, remain to be tight lipped over this particular study.
A few days ago I wrote how they [GSK] had promised to get back to me regarding my query of the outcome of the NCT00812812 clinical trial, "Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)"
Remarkably the Clinical Trials webpage has now been updated regarding this trial...no conclusion though.
The study was completed back in February this year .
Glaxo wrote me this morning with the following:
Thank you for contacting the GSK Clinical Support Helpdesk.
Unfortunately conclusion can’t be disclosed before the official CTR is released.
Adding in a further email:
The expected official release was planned to be October.
Thanks for clearing that up.
I wrote back asking if Paxil was currently recommended for use in children between the ages of 7-17 in Japan?
For back stories regarding this trial visit:
Thursday, January 15, 2009 - Email to Japanese Embassy regarding New GSK paroxetine study in Children. ClinicalTrials.gov Identifier: NCT00812812
Friday, April 03, 2009 - Japan/GSK - 329 All Over Again!
Friday, April 03, 2009 - Email to Ministry of Health - Japan
Saturday, July 25, 2009 - Paxil Study 329 All Over Again?
Friday, May 21, 2010 - Email To GlaxoSmithKline Re; Paxil Study In Children
Friday, September 24, 2010 - HEY, GLAXO!... LEAVE THOSE KIDS ALONE
Friday, May 13, 2011 - Glaxo remain tight-lipped on new Japanese Paxil study in children.
Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal
ORDER THE PAPERBACK - 'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT [PAXIL] SCANDAL'
US/CANADA COPIES HERE OR UK/IRELAND FROM CHIPMUNKA PUBLISHING